teriflunomide,ublituximab
i-mab,tg therapeutics
['#ms ', 'ublituximab', 'ultimate i', 'imab ', 'tg therapeutics', '$tgtx', 'tgtherapeutics']
#ectrims2022 kickoff: $tgtx will be presenting data from the ph3 ultimate i &amp; ii trials of #ublituximab in #ms @ ectrims this wed &amp; thurs. check out our 5 presentations @ - visit our booth-d30. schedule/details: #fearlessforpatients 
TG is a biopharmaceutical company focused on the acquisition, development & commercialization of treatments for B-cell diseases.